Skip to main content

Animations

MJFF Publications

The Michael J. Fox Foundation continually strives to communicate our scientific progress with the research community — through posters and presentations at meetings, in peer-reviewed scientific publications and with white paper reports.

From
To
  • Default content image

    LRRK2 Kinase Inhibitors of Different Structural Classes Induce Abnormal Accumulation of Lamellar Bodies in Type II Pneumocytes in Non-Human Primates but are Reversible and Without Pulmonary Functional Consequences

    Marco A.S. Baptista1, Kalpana M. Merchant1, Sakshi Bharghava2, Diane Bryce3, Michael Ellis3, Anthony A. Estrada4, Matthew Fell3, Reina N. Fuji4, Paul Galatsis2, Sue Hill3, Warren D. Hirst2,…
    Learn more

  • Default content image

    Effect of selective LRRK2 kinase inhibition on nonhuman primate lung

    Inhibition of the kinase activity of leucine-rich repeat kinase 2 (LRRK2) is under investigation as a possible treatment for Parkinson's disease. However, there is no clinical validation as yet, and…
    Learn more

  • Default content image

    Use of an Online Portal to Facilitate Clinical Trial Recruitment: A Preliminary Analysis of Fox Trial Finder (Article)

    Journal of Parkinsons Disease An evaluation of Fox Trial Finder -- MJFF's online tool that matches eligible volunteers to local, recruiting clinical trials -- characterizes potential research…
    Learn more

  • Default content image

    The hTH-GFP Reporter Rat Model for the Study of Parkinson's Disease

    Lorraine Lacovitti, Xiaotao Wei, Jingli Cai, Eric W. Kostuk, Ruihe Lin, Alexander Gorodinsky, Philip Roman, Gretchen Kusek, Sonal S. Das, Audrey Dufour, Terina N. Martinez, and Kuldip D. Dave …
    Learn more

  • Default content image

    Characterization, comparison, and cross-validation of in vivo alpha-synuclein models of parkinsonism.

    Terina. N. Martinez1, Michael Sasner2, Mark T. Herberth3, Robert C. Switzer III4, S.O. Ahmad5, Kelvin C. Luk6, Sylvie Ramboz7, Andrea E. Kudwa7, Deniz Kirik8, Joe Flores8, Ronald J. Mandel9,…
    Learn more

  • Default content image

    Therapeutic Development Paths for Cognitive Impairment in Parkinson's Disease: Report of a Regulatory Roundtable

    Journal of Parkinsons Disease Cognitive impairment is a common occurrence in Parkinson's disease (PD), although the severity and specific presentation varies across patients. Initial deficits,…
    Learn more

  • Default content image

    Overcoming obstacles to repurposing for neurodegenerative disease

    Annals of Clinical and Translational Neurology Repurposing Food and Drug Administration (FDA)-approved drugs for a new indication may offer an accelerated pathway for new treatments to patients but…
    Learn more

Articles authored by Rachel Dolhun, MD, a movement disorder specialist on staff at MJFF, offer a practical review of topics related to Parkinson's disease for practicing clinicians.

From
To

No results were found.

Female researcher pipetting in lab.

Breaking Research Updates

Read the latest developments in the field’s understanding and treatment of Parkinson’s disease.

Read Research News
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.